Impacts of drug interactions on pharmacokinetics and the brain transporters: A recent review of natural compound-drug interactions in brain disorders

Bikram Khadka, Jae Young Lee, Eui Kyun Park, Ki Taek Kim, Jong Sup Bae

Research output: Contribution to journalReview articlepeer-review

5 Scopus citations

Abstract

Natural compounds such as herbal medicines and/or phyto-compounds from foods, have frequently been used to exert synergistic therapeutic effects with anti-brain disorder drugs, supple-ment the effects of nutrients, and boost the immune system. However, co-administration of natural compounds with the drugs can cause synergistic toxicity or impeditive drug interactions due to changes in pharmacokinetic properties (e.g., absorption, metabolism, and excretion) and various drug transporters, particularly brain transporters. In this review, natural compound–drug interactions (NDIs), which can occur during the treatment of brain disorders, are emphasized from the perspective of pharmacokinetics and cellular transport. In addition, the challenges emanating from NDIs and recent approaches are discussed.

Original languageEnglish
Article number1809
Pages (from-to)1-20
Number of pages20
JournalInternational Journal of Molecular Sciences
Volume22
Issue number4
DOIs
StatePublished - 2 Feb 2021

Keywords

  • Blood–brain barrier (BBB) and blood–cerebrospinal fluid barrier (BCSFB)
  • Brain disorders
  • Drug transporters
  • Natural compound–drug interactions (NDIs)
  • Pharmacokinetics

Fingerprint

Dive into the research topics of 'Impacts of drug interactions on pharmacokinetics and the brain transporters: A recent review of natural compound-drug interactions in brain disorders'. Together they form a unique fingerprint.

Cite this